The oral treatment of urinary schistosomiasis in Egyptian patients with 'Oltipraz'.

Oltipraz was given in a daily dose of 1.5 gm for two days to 40 patients with haematobiasis. Cure rates of 92.5% and 82.5% were obtained after two and six months follow-up examinations. A high proportion of egg-reduction of 97% and 98% was obtained in 'egg-positive' cases. Clinical and biological tolerance of patients to the drug was excellent. The drug is easy in administration, given orally and with minimal side effects.